Additional clinical details to power your research
You need a deep understanding of your patient population to conduct high-quality research, move the needle on treatment options and ultimately improve patient health outcomes. But sometimes, the information you want to analyze isn’t easily accessible in traditional structured clinical and claims data.
Maybe you want to know more about patient symptoms before and after diagnosis, how they’ve reacted to treatments and their quality of life.
That’s where Optum enriched clinical data come in.
With research-ready, disease-area specific data extracted using natural language processing (NLP) on clinical notes and radiology reports, our enriched cohorts build upon our existing electronic health record (EHR) data with deeper depth and breadth of key data elements.
These data enable a more complete view of the patient care journey, accelerating your research and boosting your insights.
Access rich, disease-area specific patient data
Reduce time to analysis
Data are research-ready, meaning you can dive right into exploring the data and conducting analyses without the need to comb through and extract information from unstructured notes or radiology reports yourself.
Our expert teams develop detailed requirements for each enriched disease area to generate meaningful variables from millions of clinician notes.
The data you receive are normalized, curated and structured into pre-packaged tables that can be easily analyzed alongside the rest of your licensed Optum data.
Generate better research questions and outputs
Unlock new information only readily found in clinical notes data. With more data on the patient journey, such as reasons for treatment discontinuation or caregiver observations, you can conduct more robust research and produce more generalizable study results.
Tackle business and research questions that you previously struggled to answer with more comprehensive insight into the whole patient and the whole disease.
Conduct research with greater confidence
With a compliantly integrated data source bringing together structured and unstructured sources, you get more available data points per patient, from pre-diagnosis through follow-up.
Working with additional data fields can help improve the quality of your overall research and conclusions.
Key benefits
Curated, clinically relevant concepts
Our enriched data prioritize high-need components that provide you with new, pertinent clinical context for your disease area of interest.
Richer data combined with foundational data
Enriched data maintain the attributes of baseline Optum clinical data — longitudinal, multi-payer, multi-specialty — and span sites of care.
Highly usable, analysis-ready tables
Forgo the in-house legwork of extracting details from unstructured data with packaged tables, transformed and structured by our expert team.
Trusted source data
With more than 300 publications in the past 5 years, clients trust our real-world data to support submissions to peer-reviewed journals.
Key concepts offer supplementary details to catalyze research
Follow the path to greater insights with the sample Alzheimer’s patient journey shown here. Get more information about your disease area of interest from initial presentation to ongoing follow-ups. Available data include physical exam results, imaging scans, medication side effects, disease progression and more.
Disease area: Alzheimer’s disease
Initial presentation
Base clinical and claims data:
- Demographics (age, gender, race, ethnicity, etc.)
- Existing health conditions, family history of dementia, medication
- Physical examinations performed
Enriched clinical data:
- Physical exam findings ruled out causes
- Patient and caregiver report on memory lapses, confusion, difficulty in completing familiar tasks, etc.
- Cognitive screening tests to quantify cognitive impairment
Diagnosis of MCI
Base clinical and claims data:
- Mild cognitive impairment (MCI) diagnosis
Enriched clinical data:
- More extensive neuropsychological testing
- Magnetic resonance imaging (MRI) and computerized tomography (CT) scans to detect brain structure changes
- Positron emission tomography (PET) scans to assess amyloid and tau protein deposits
- Blood test and cerebrospinal fluid (CSF) analysis for biomarkers associated with Alzheimer’s disease (AD)
- Identification of genetic markets like APOE4
Progression to AD
Base clinical and claims data:
- Lab results
- Alzheimer’s disease diagnosis
Enriched clinical data:
- Repeated imaging analysis to monitor disease progression
- Patient or caregiver reported progression
- Symptoms such as aggression and agitation
Treatment
Base clinical and claims data:
- Pharmacological treatment: prescription, cost
Enriched clinical data:
- Changes in medication and side effects
- Patient responses to treatments
Ongoing follow-up
Base clinical and claims data:
- Mortality
Enriched clinical data:
- Continuous collection of progression and outcomes
Product information and resources
-
Download fact sheet
PDF
Fact sheet
Improve your Alzheimer’s data set
Get an overview of our enriched Alzheimer’s disease cohort and potential use cases to fuel your research.
Complementary solutions
Optum EHR Data
Market Clarity Data
Optum Claims Data
Related healthcare insights
Article
Learn about natural language processing (NLP) challenges and opportunities in the real-world data (RWD) space from Optum® NLP experts.
Article
Using real-world data (RWD) that are not fit for purpose can waste time and money. Review 6 simple steps to guide your research towards the right data.
White paper
Natural language processing (NLP) systems allow us to draw insights from billions of unstructured medical notes. Learn more about our methodology.